China Life Insurance Co, the largest insurer in China by market capitalisation, reported that its 2024 net profit may have more than doubled, supported by strong returns on equity investments amid ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024. With 2025 here, and in the midst of life sciences ...

As Per the SNS Insider,“The Process Automation and Instrumentation Market Size was valued at USD 70 ... drive this growth in countries like China, India, and Japan. Leading companies such ...

This guidance assumes stable demand conditions and no significant improvement in market ... life sciences instrumentation. Geopolitical and regulatory risks, including potential impacts from U.S ...

The life science market is projected to grow with a compound annual growth rate (CAGR) of 10.28% from 2024 to 2033. This robust growth is fueled by technological breakthroughs, increasing demand for ...

China Life Insurance Co., the nation’s largest insurer by market value, said 2024 profit may have jumped as much as 144% from the previous year as the country’s stock rally boosted investment returns.

TD Cowen analysts have noted the U.S. government's intent to restrict China's access to specific life science instrumentation, estimating that the revenue exposure to the ban is limited for ...

In Part 6 of the Life Sciences Industry Report, we’ve collated key thought leadership from 2024 that looks at ways in which to navigate such complexities, dives into both the opportunities that ...